chr7-4785540-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014855.3(AP5Z1):āc.988C>Gā(p.Leu330Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000235 in 1,612,714 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Synonymous variant affecting the same amino acid position (i.e. L330L) has been classified as Likely benign.
Frequency
Consequence
NM_014855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AP5Z1 | NM_014855.3 | c.988C>G | p.Leu330Val | missense_variant | 9/17 | ENST00000649063.2 | |
AP5Z1 | NM_001364858.1 | c.520C>G | p.Leu174Val | missense_variant | 8/16 | ||
AP5Z1 | XM_047421098.1 | c.652C>G | p.Leu218Val | missense_variant | 7/15 | ||
AP5Z1 | NR_157345.1 | n.1081C>G | non_coding_transcript_exon_variant | 9/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AP5Z1 | ENST00000649063.2 | c.988C>G | p.Leu330Val | missense_variant | 9/17 | NM_014855.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000734 AC: 18AN: 245212Hom.: 0 AF XY: 0.0000974 AC XY: 13AN XY: 133538
GnomAD4 exome AF: 0.000250 AC: 365AN: 1460490Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 176AN XY: 726468
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74372
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 48 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 29, 2022 | This variant has not been reported in the literature in individuals affected with AP5Z1-related conditions. This variant is present in population databases (rs376680652, gnomAD 0.02%). This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 330 of the AP5Z1 protein (p.Leu330Val). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Aug 24, 2021 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2024 | The c.988C>G (p.L330V) alteration is located in exon 9 (coding exon 9) of the AP5Z1 gene. This alteration results from a C to G substitution at nucleotide position 988, causing the leucine (L) at amino acid position 330 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at